Aim: Randomised trials using drug-eluting stents (DES) in ST elevation myocardial infarction (STEMI) have shown mixed results, and excluded patients at the highest risk of adverse outcomes. We aimed to determine the real world clinical outcomes of DES and compare these with bare-metal stents (BMS) in an unrestricted observational study of patients presenting with STEMI. Methods: 564 consecutive patients undergoing primary PCI for STEMI were prospectively enrolled in the Melbourne Interventional Group registry (August 2004 to May 2006). The choice of using DES was at the operator's discretion, yet restricted to patients considered at highest risk of restenosis [e.g. diabetes, long lesions (> 20 mm) and small target vessels (< 2.5 mm)]....
Objectives The authors investigated the relative safety and efficacy of different drug-eluting stent...
ObjectivesThis study sought to compare the long-term effects of drug-eluting stent (DES) compared wi...
AIMS: To assess mortality after drug-eluting stent (DES) or bare-metal stent (BMS) for ST-segment el...
ObjectivesWe sought to examine the clinical outcomes of patients treated with drug-eluting stents (D...
WOS: 000464326000010Objective: The aim of this study was to compare the effectiveness and safety of ...
(Objective) under bar: The objective of this study is to investigate the clinical outcome of a large...
Aim: To evaluate the safety and effect on long-term outcomes of an approach that selectively uses dr...
BACKGROUND: Recent randomized trials have demonstrated conflicting results regarding the use of drug...
Background: Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patien...
Background: To date, no specific drug-eluting stent (DES) has fully proven its superiority over othe...
OBJECTIVE: The superiority of drug-eluting stents (DES) over bare-metal stents (BMS) in patients wit...
BACKGROUND: To date, no specific drug-eluting stent (DES) has fully proven its superiority over othe...
Objective: The aim of this study was to compare the effectiveness and safety of drug eluting stents ...
BACKGROUND: The long-term safety and efficacy of drug eluting stents (DES) implanted during prima...
To date, no specific drug-eluting stent (DES) has fully proven its superiority over others in patien...
Objectives The authors investigated the relative safety and efficacy of different drug-eluting stent...
ObjectivesThis study sought to compare the long-term effects of drug-eluting stent (DES) compared wi...
AIMS: To assess mortality after drug-eluting stent (DES) or bare-metal stent (BMS) for ST-segment el...
ObjectivesWe sought to examine the clinical outcomes of patients treated with drug-eluting stents (D...
WOS: 000464326000010Objective: The aim of this study was to compare the effectiveness and safety of ...
(Objective) under bar: The objective of this study is to investigate the clinical outcome of a large...
Aim: To evaluate the safety and effect on long-term outcomes of an approach that selectively uses dr...
BACKGROUND: Recent randomized trials have demonstrated conflicting results regarding the use of drug...
Background: Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patien...
Background: To date, no specific drug-eluting stent (DES) has fully proven its superiority over othe...
OBJECTIVE: The superiority of drug-eluting stents (DES) over bare-metal stents (BMS) in patients wit...
BACKGROUND: To date, no specific drug-eluting stent (DES) has fully proven its superiority over othe...
Objective: The aim of this study was to compare the effectiveness and safety of drug eluting stents ...
BACKGROUND: The long-term safety and efficacy of drug eluting stents (DES) implanted during prima...
To date, no specific drug-eluting stent (DES) has fully proven its superiority over others in patien...
Objectives The authors investigated the relative safety and efficacy of different drug-eluting stent...
ObjectivesThis study sought to compare the long-term effects of drug-eluting stent (DES) compared wi...
AIMS: To assess mortality after drug-eluting stent (DES) or bare-metal stent (BMS) for ST-segment el...